Clinical usefulness of evaluation of portal circulation by per rectal portal scintigraphy with technetium-99m pertechnetate. 1995

S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
Third Department of Internal Medicine, Osaka City University Medical School, Japan.

OBJECTIVE Portal circulation, in particular the contribution of the inferior mesenteric vein, can be evaluated in a relatively noninvasive way by per rectal portal scintigraphy (J Nucl Med 1988; 29:460-5). The clinical usefulness of the method was evaluated. METHODS A solution containing technitium-99m pertechnetate was instilled into the rectum, and serial scintigrams were taken while radioactivity curves for the liver and heart were recorded sequentially. By analyses of the curves, the per rectal portal shunt index (SI) was calculated. RESULTS The SI was higher for disorders that were more severe, increasing in the order of chronic persistent hepatitis, chronic aggressive hepatitis, and cirrhosis, and the SI was higher in cirrhotic patients than in patients with chronic hepatitis or in healthy subjects. The SI was significantly higher when a complication (varices, ascites, or encephalopathy) was present. Correlation between the SI and classic indicators for functional reserve was significant. The SI was significantly related to survival according to results of regression analysis by Cox's proportional hazards model. On the basis of the SI when patients were first examined, the patients with cirrhosis were divided into three groups of roughly equal size: group A, SI under 30%; group B, SI between 30 and 70%; and group C, SI over 70%. The survival rate was lower in group B than in A, lower in group C than in A, and lower in group C than in B. CONCLUSIONS This method is clinically useful, especially in establishing the prognosis.

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D011168 Portal System A system of vessels in which blood, after passing through one CAPILLARY BED, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system. Portal Systems,System, Portal,Systems, Portal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013670 Sodium Pertechnetate Tc 99m A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints. Pertechnetate Sodium,Tc 99m-Pertechnetate,Technetium Tc 99m Pertechnetate,99Tc-Pertechnetate,99TcmO4,99mTcO4,Pertechnetate,Technetium Pertechnetate,Technetium Tc 99m O(4),Technetium-99mTc-pertechnetate,99Tc Pertechnetate,99m-Pertechnetate, Tc,Pertechnetate, Technetium,Sodium, Pertechnetate,Tc 99m Pertechnetate,Technetium 99mTc pertechnetate
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
December 1993, Hiroshima journal of medical sciences,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
February 1995, Journal of hepatology,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
January 2003, Hepato-gastroenterology,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
December 2007, Singapore medical journal,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
March 1992, Journal of hepatology,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
January 2003, Hepato-gastroenterology,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
May 1990, The American journal of gastroenterology,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
December 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
March 1981, Kaku igaku. The Japanese journal of nuclear medicine,
S Shiomi, and T Kuroki, and T Ueda, and T Takeda, and N Ikeoka, and S Nishiguchi, and S Nakajima, and K Kobayashi, and H Ochi
January 1984, Kaku igaku. The Japanese journal of nuclear medicine,
Copied contents to your clipboard!